ABI, Roche Win $15.6M in Additional Patent Damages from MJ Research | GenomeWeb

Applied Biosystems celebrated a victory and suffered a defeat this week in its battle to uphold its intellectual property in the areas of PCR and real-time PCR.

On March 30, a US Court awarded ABI and Roche Molecular Systems $15.6 million in additional damages in the companies' PCR-related patent litigation against MJ Research and two of its founders. The increased damages amount to $35.4 million plus attorneys' fees that MJ Research and its founding brothers will be required to pay to ABI and Roche.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.